Skip to content

KLRS KLRS Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.23B+19.0%
Amgen logo
AmgenAMGN
$12.76B+12.0%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$9.3M+58.3%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$8.68M+0.2%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$9.86M+40.0%
Regenxbio logo
RegenxbioRGNX
$5.51M+84.6%

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's other non-current assets?
KLRS (KLRS) reported other non-current assets of $1.75M in Q1 2026.
How has KLRS's other non-current assets changed year-over-year?
KLRS's other non-current assets increased by 327.6% year-over-year, from $410K to $1.75M.
What is the long-term trend for KLRS's other non-current assets?
Over 4 years (2021 to 2025), KLRS's other non-current assets has grown at a -3.6% compound annual growth rate (CAGR), from $1.1M to $953K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.